18 June 2026
18 June 2026
In a midyear report, PwC said that a surge in deals eclipsing the billion-dollar mark fuelled M&A momentum.
Like Lundbeck’s bocunebart, Vedana’s clinical pipeline targets PACAP – an approach that has shown varying levels of success in clinical trials thus far.
AbCellera will conduct discovery and early-stage research activities on two initial programmes.
Bristol Myers Squibb (BMS) has revealed clinical data for two pipeline candidates in multiple myeloma (MM) at the European Hematology Association Congress (EHA) 2026, held from June 11–14.
The companies aim to create a tablet-form treatment to improve the safety and absorption rates of peptide drugs.
Key opinion leaders interviewed by GlobalData have anticipated the TRIUMPH-1 readout with considerable interest.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
